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We reviewed  patients with  herpes zoster ophthalmicus (HZO)
seen at the  Irrua Specialist Teaching Hospital and the Central
Hospital in Benin City, Edo State, Nigeria, for a period of 10
years from July 1993. Of the 44 HZO patients,  28 (64%) were
HIV-positive, 7 (16%) were HIV-negative and in 9 (20%) the
status was unknown. Most patients (89%) who were HIV-
positive were below the age of 50 years, while those who were
HIV-negative (71%) were generally above the age of 50 years.
This is a clear deviation from the past when HZO was seen
mostly in the elderly.
Herpes zoster results from recrudescence of latent varicella
zoster virus from the dorsal root of cranial nerve ganglia
present since primary infection with varicella (chickenpox).
The commonest causes of varicella recrudescence are decline in
cell-mediated immunity related to age,1 reduced immunity
associated with some malignancies such as lymphoma,
treatment of malignancies with chemotherapy or radiotherapy,
HIV infection, and use of immunosuppressant drugs (such as
steroids) after organ transplant surgery or for disease
management. HZO occurs when the recrudescence is in the
ophthalmic branch of the trigeminal nerve. It presents as
vesiculo bullous dermatitis on one side of the face, usually
involving the scalp. The infection is distributed along the
ophthalmic division of the trigeminal nerve and does not cross
the midline. Involvement of the tip of the nose is significant
because it implies involvement of the nasociliary nerve and
such cases usually involve the cornea on the same side (Fig. 1).
Conclusion
Although parents have the right to dignity,6 privacy7 and
freedom of conscience and religion,8 the High Court has held
that such rights are superseded by a child’s right to life in cases
where the child’s life is at risk. In South Africa, as in other
countries,9 refusals of blood transfusions during medical
emergencies for minor children by parents solely on religious
grounds are unlawful.  Thus it is no longer necessary for
doctors to seek a court order every time parents refuse to allow
their children to receive a life-saving blood transfusion solely
on religious grounds.  In such circumstances the doctors will be
acting lawfully if they proceed with a blood transfusion,
against the wishes of the parents, in order to save the child’s
life.
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The occurrence of varicella zoster virus dermatitis in a person
below the age of 50 years should suggest the possibility of an
immunosuppressive condition.2
Since the initial description of eye abnormalities in HIV-
positive patients in 1982,3 numerous reports have described the
spectrum and natural history of HIV-associated eye disorders,
which affect 70 - 80% of all patients at some point during their
illness.4
The majority of patients were managed as outpatients using
topical acyclovir for the rashes and acyclovir or idoxuridine
(Herpidu) for those with corneal involvement. This was
because of the non-availability of highly active antiretroviral
therapy and high cost of systemic antiretroviral agents in both
centres (as in most hospitals across the country). Supportive
treatment for pain relief and anti-inflammatory agents were
given when indicated. 
HZO is a known marker of HIV/AIDS in Africa.5-7 Its ocular
effects may be extremely severe (Fig. 2). Patients with
ophthalmic herpes zoster who are HIV-negative tend to have
less severe infection8 and also recover faster than those who are
HIV-positive.9
All adults presenting with HZO should be screened for HIV
infection, especially patients below the age of 50 years and if
there are no obvious predisposing factors that would explain a
reduction in immunity.
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Fig. 1. HZO with ocular involvement (central corneal ulceration
staining with fluorescein that resolved with a central leucoma).
Fig. 2. A 22-year-old woman with severe scarring of the left face from
HZO, and an atrophied eye, a complication following a perforated
corneal ulceration.
